行情

TENX

TENX

Tenax Therapeut
NASDAQ

实时行情|Nasdaq Last Sale

0.5980
+0.0340
+6.03%
交易中 13:37 04/02 EDT
开盘
0.5640
昨收
0.5640
最高
0.5980
最低
0.5500
成交量
3.93万
成交额
--
52周最高
2.160
52周最低
0.2500
市值
454.97万
市盈率(TTM)
-0.1011
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测TENX价格均价为4.225,最高价位4.450,最低价为4.000。

EPS

TENX 新闻

更多
  • 瑞幸称相关人员已停职并被接任 有员工准备另谋出路
  • 新浪财经综合 · 24分钟前
  • “大空头”查诺斯:需对因疫情短暂受益的“病毒股”保持谨慎
  • 新浪美股 · 51分钟前
  • Recode:亚马逊禁止商家向公众销售N95和医用外科口罩
  • 新浪美股 · 52分钟前
  • 你需要了解:新冠病毒将重铸美国科技版图
  • 新浪财经综合 · 53分钟前

所属板块

生物技术和医学研究
+1.51%
制药与医学研究
+1.06%

热门股票

代码
价格
涨跌幅

TENX 简况

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
展开

微牛提供Tenax Therapeutics Inc(NASDAQ-TENX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的TENX股票新闻,以帮助您做出投资决策。